Nurix Therapeutics
NRIX
NRIX
103 hedge funds and large institutions have $1.05B invested in Nurix Therapeutics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
18% less capital invested
Capital invested by funds: $1.28B → $1.05B (-$237M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $13K
Holders
103
Holding in Top 10
7
Calls
–
Puts
$13K
Top Buyers
| 1 | +$25.4M | |
| 2 | +$15.2M | |
| 3 | +$13.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.8M |
| 5 |
Morgan Stanley
New York
|
+$9.26M |
Top Sellers
| 1 | -$167M | |
| 2 | -$28.8M | |
| 3 | -$3.29M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$2.68M |
| 5 |
PCM
Pinz Capital Management
New York
|
-$2.25M |